A token leaks. A bad package slips in. A login trick works. An old tool shows up again. At first, it feels like the usual mess. Then you see the pattern: attackers are not always breaking in. They are ...
It’s time to switch to a new development tool for SQL Server and Azure SQL. Here’s how to get started with the MSSQL ...
On Wednesday, a survey of 700 software engineering leaders across five countries found that AI coding tools have transformed ...
The software engineering landscape in 2026 has reached a definitive inflection point: AI agents now autonomously resolve over 70% of software issues, and 30-40% of code in leading repositories is ...
Homegrown in Northern California, just east of San Francisco, Bo grew up spoiled with the best weather on the planet. For 17 years, he never knew how good he had it until he moved to Maryland for ...
Want to start a career in AI? Explore the top AI jobs in India for 2026, including ML Engineer salaries, required skills like ...
As artificial intelligence continues to rewrite the rules in countless industries, pharma companies are increasingly getting on board—with their AI tie-ups ranging from narrow projects to ...
STATE COLLEGE | Penn State won’t hold its annual Blue-White spring game until April 25, but the quarterbacks have already experienced throwing in Beaver Stadium — virtually. Using virtual reality ...
Amazon Web Services plans to deploy processors designed by Cerebras inside its data centers, the latest vote of confidence in the startup, which specializes in chips that power artificial-intelligence ...
Florida's Python Elimination Program pays certified hunters to remove the invasive snakes from the Everglades. Burmese pythons have caused a severe decline in native small mammal populations in South ...
President Donald Trump is weighing the option of deploying special forces on the ground to seize Iran’s near-bomb-grade uranium, as officials grow increasingly concerned the stockpile may have been ...
- AZURE-1 and AZURE-4 to form the basis of Mirum’s U.S. BLA Submission Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading rare disease company, today announced completion of enrollment in the Phase ...